Journal of Gastrointestinal and Liver Diseases

Papers
(The TQCC of Journal of Gastrointestinal and Liver Diseases is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects22
Association of Functional Dyspepsia with Depression and Anxiety: A Systematic Review18
Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis17
Deep Learning Algorithm for the Confirmation of Mucosal Healing in Crohn’s Disease, Based on Confocal Laser Endomicroscopy Images17
Probiotics in the Treatment of Inflammatory Bowel Disease in Adulthood: A Systematic Review16
What is the Impact of the Proportion of Solid Necrotic Content on the Number of Necrosectomies during EUS-Guided Drainage using Lumen-Apposing Metallic Stents of Pancreatic Walled-off Necrosis ?15
Burning Mouth Syndrome Etiology: A Narrative Review14
The Effect of Linked Color Imaging for Adenoma Detection. A Meta-analysis of Randomized Controlled Studies14
Fatty Liver Index as a Simple and Useful Predictor for 10-year Cardiovascular Disease Risks Determined by Framingham Risk Score in the General Korean Population14
Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide13
Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment13
Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors12
Lack of association of the esophageal microbiome in adults with eosinophilic esophagitis compared with non-EoE controls12
Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease11
Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry10
LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling9
The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease8
Bowel Ultrasound: a Non-invasive, Easy to Use Method to Predict the Need to Intensify Therapy in Inflammatory Bowel Disease Patients8
Digestive Toxicities Secondary to Immune Checkpoint Inhibition Therapy – Reports of Rare Events. A Systematic Review8
MEFV Mutations in IBD Patients: A Systematic Review and Meta- analysis8
HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons7
Negative Effects of Endoscopists’ Fatigue on Colonoscopy Quality on 34,022 Screening Colonoscopies7
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available7
Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series7
The Gut Microbiota Profile in Heart Failure Patients: A Systematic Review7
Gastrointestinal Manifestations and Treatment Options in Fabry Disease Patients. A Systematic Review6
KCNN4 Expression Is Elevated in Inflammatory Bowel Disease: This Might Be a Novel Marker and Therapeutic Option Targeting Potassium Channels6
Environmental and Dietary Risk Factors for Colonic Diverticulosis and Diverticulitis6
Lifestyle and Dietary Factors Associated with Inflammatory Bowel Disease among Jordanian Patients6
Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis6
Automatic Diagnosis of High-Resolution Esophageal Manometry Using Artificial Intelligence6
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study6
Serum Galectin-3 in Hepatitis C Virus Infection Declines after Successful Virus Eradication by Direct-Acting Antiviral Therapy5
Epidemiology of Irritable Bowel Syndrome in Albania5
Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis5
Effect of Proton Pump Inhibitor Treatment in “PPI Non-responsive” Patients with Eosinophilic Esophagitis5
The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the5
Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience5
Epidemiology and Burden of Disorders of Gut-Brain Interaction in Romania: A Subgroup Analysis of the Rome Foundation Global Epidemiology Study5
Incidence, Predictive Factors, Clinical Characteristics and Outcome of Non-variceal Upper Gastrointestinal Bleeding – A Prospective Population-based Study from Hungary5
The Influence of Intravenous Lidocaine Infusion on Postoperative Outcome and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Patients. A Pilot Study5
Yoga Therapy in Functional Dyspepsia. A Narrative Review4
Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation4
The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center4
Management of Hepatic Sarcoidosis4
Neurological Manifestations and Psychiatric Disorders in the Course of Inflammatory Bowel Diseases4
Transarterial Chemoembolization plus Apatinib with or without Camrelizumab for the Treatment of Advanced HBV-related Hepatocellular Carcinoma4
Different Prevalence of Alarm, Dyspeptic and Reflux Symptoms in Patients with Cardia and Non-cardia Gastric Cancer4
Safety and Efficacy of TACE + Lenvatinib in Treating Advanced Hepatocellular Carcinoma: A Systematic Review and Meta- analysis4
Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan4
Chronic Pancreatitis and Diabetes of Exocrine Pancreas / Type 3c Diabetes Mellitus / Post-pancreatitis Diabetes Mellitus4
Diet and Gut Inflammation: The Effect of Diet on Inflammatory Markers in Inflammatory Bowel Disease – A Scoping Review4
Impact of Synbiotic Therapy on the Quality of Life in Patients with Mild-to-Moderately Active Ulcerative Colitis4
Coeliac Disease and Probiotics: Clinicians Need to Provide the Evidence Base for this Unmet Need4
Applications of Artificial Intelligence in the Automatic Diagnosis of Focal Liver Lesions: A Systematic Review4
Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn‘s Disease Patients: Results from the BIOMIR Study4
Comparison of Hepatic Arterial Infusion Chemotherapy and Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis4
Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome4
Probiotic Use in Celiac Disease: Results from a National Survey4
Examination of Abnormal Alpha-synuclein Aggregates in the Enteric Neural Plexus in Patients with Ulcerative Colitis4
Influence of the Primary Tumor Location on the Pattern of Synchronous Metastatic Spread in Patients with Stage IV Colorectal Carcinoma, According to the 8 th Edition of the AJCC Staging System4
Bile Composition - which Components Can Have Clinical Significance? A Review of the Literature4
Update on the Role of Rifaximin in Digestive Diseases4
Romanian Guidelines for the Diagnosis and Treatment of GERD-induced Respiratory Manifestations4
MicroRNAs and Treatment with Somatostatin Analogs in Gastro- Entero-Pancreatic Neuroendocrine Neoplasms: Challenges in Personalized Medicine4
Vegan Diet Advice Might Benefit Liver Enzymes in Nonalcoholic Fatty Liver Disease: an Open Observational Pilot Study4
Validation and Performance of Chronic Liver Disease Questionnaire (CLDQ-RO) in the Romanian Population4
Pregnancy in a liver transplant patient treated with everolimus and tacrolimus4
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study4
Searching for a Definition of Refractory Irritable Bowel Syndrome: a Systematic Review and Meta-analysis3
Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis3
Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma3
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission3
Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic3
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab3
Impact of solid necrotic content on the outcome of endoscopic ultrasound guided transmural drainage of walled off pancreatic necrosis3
Prevalence of Autoimmune-phenomena behind Chronic Gastritis of Unknown Origin, and their Role in the Poor Histological Outcome of the Stomach: A Single-centre, Retrospective Cross-sectional Study3
Gastric Melanoma of Unknown Primary3
Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis3
Coping Strategies and Irritable Bowel Syndrome: A Systematic Review3
Different Variation of Intra-familial Body Mass Index subjected to Covid-19 Lockdown3
Enhancing Metformin Effects by Adding Gut Microbiota Modulators to Ameliorate the Metabolic Status of Obese, Insulin-Resistant Hosts3
Statins and Risk of Cholangiocarcinoma: A Systematic Review and Meta-analysis3
Clinical, Endoscopic, and Histopathologic Observations in Gastrointestinal Amyloidosis3
Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis3
Nurse Practitioners in Inflammatory Bowel Disease: The Emerging Role of the IBD Care Manager3
Six-Minute Walking Test as a Predictor of Clinical Decompensation in Patients with Cirrhosis3
Burning mouth syndrome needs to consider the gut-brain axis from three types of pain: nociceptive, neuropathic, and nociplastic pain3
Low Aspartate Aminotransferase (AST)/Alanine Aminotransferase (ALT) Ratio Associated with Increased Cardiovascular Disease and its Risk Factors in Healthy Japanese Population3
Contribution of MicroRNAs in the Development of Irritable Bowel Syndrome Symptoms3
Adipopenia Is the Rapid Screening Tool that Best Predicts Mortality in Patients with Decompensated Cirrhosis: Results of a Prospective Study3
Fighting Hepatitis C in a COVID-19 ecosystem. Public health policies are needed more than ever3
Treatment Intensity, not Age, Affects Survival Time of Patients with Advanced Pancreatic Cancer3
A spontaneous rupture of lung metastasis from hepatocellular carcinoma after the introduction of lenvatinib3
Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence3
A Primer into the Current State of Artificial Intelligence in Gastroenterology3
VNTR Polymorphism in Intron 4 of the eNOS Gene and the Risk of Gastrointestinal Bleeding: A Case-control Study2
Outcomes, Mortality, and Cost Burden of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis2
Acceptability of Hybrid Endoscopic Submucosal Dissection Using Multifunctional Snare for Small-sized Gastric Neoplasms: A Prospective Observational Study2
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD2
Comparative Efficacy and Tolerability of Janus Kinase Inhibitor Therapies for Moderate to Severe Crohn’s Disease: Α Network Meta-analysis2
Thrombospondin 1 and Nuclear Factor Kappa B Signaling Pathways in Non-alcoholic Fatty Liver Disease2
Endoscopic Application of Purastat® in the Treatment of Solitary Rectal Ulcer Syndrome2
Helicobacter Pylori Colonization Density is an Important Risk Factor for Eradication Therapy2
Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis2
Biomarkers in Inflammatory Bowel Diseases: Predicting the Indication and the Effect of Biologics2
COVID-19 induced haemobilia: a novel entity2
Do Patient Delay and Diagnostic Delay Influence Long Term Survival in Patients with Gastric Cancer?2
Oseltamivir-induced upper gastrointestinal bleeding2
Sterile Fecal Filtrate From A Healthy Donor Improves Microbial Diversity In Patients With Hepatic Encephalopathy2
The p53 Family of Transcription Factors Represses the Alpha- fetoprotein Gene Expression in Hepatocellular Carcinoma2
Nurse Administered Propofol Sedation (NAPS) versus On-call Anesthesiologist Administered Propofol Sedation (OAPS) in Elective Colonoscopy2
The Colorectal Cancer Screening Program in Romania - ROCCAS - is Ready for the Implementation at National Level2
Validation of the Reflux Disease Questionnaire for a Turkish Population2
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure2
Exploring the Impact of Trauma and Psychosocial Processes on the Quality of Life in Individuals Living with Inflammatory Bowel Disease2
Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection2
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study2
Anastomotic Leakage after Gastrectomy for Gastric Cancer2
Holmium-166 Microspheres are Visible in Target Liver Lesions on Unenhanced Computed Tomography2
Early onset of intrahepatic cholestasis of pregnancy: a case report2
Blood Metabolomic Signatures to Identify Bacterial Infection in Patients with Decompensated Cirrhosis2
The Role of Sphere Size in the Context of Pancreatin Therapy for Exocrine Pancreatic Insufficiency: A Systematic Review2
Activated Hepatic Stellate Cells (Ito Cells) - Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study2
Fomepizole as an emerging adjunct in treating severe acetaminophen toxicity: a case report and a brief review2
Lenvatinib as First-line Treatment of Hepatocellular Carcinoma in Patients with Impaired Liver Function in Advanced Liver Cirrhosis: Real World Data and Experience of a Tertiary Hepatobiliary Center2
0.16190409660339